Allele loss of tumour suppressor genes on chromosome 17 in human testicular germ cell tumours

International Journal of Oncology

Volumn 9, Issue 5, 1996, Pages 1087-1090

  Van Der Looij, Marco ^a   Eid, Hanna ^a   Bak, Mihály ^a   Bodrogi, István ^a   Oláh, Edith ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

BRCA1; chromosome 17; loss of heterozygosity; testis cancer; TP53

Indexed keywords

ARTICLE; CHROMOSOME 17; CLINICAL ARTICLE; GERM CELL TUMOR; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TESTIS TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0029958750     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.5.1087     Document Type: Article

References (27)

1. Gilliland FD, Key CR: Male genital cancers. Cancer (Suppl) 75: 295-315, 1994.
2. Atkin NB, Baker MC: Specific chromosome change, i(12p) in testicular tumours. Lancet 2: 1349, 1982.
3. Rodriguez E, Mathew S, Reuter V, Ilson DH, Bosl GJ, Chaganti RSK: Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res 52: 2285-2291, 1992.
4. Murty VVVS, Houldsworth J, Baldwin S, Reuter V, Hunziker W, Besmer P, Bosl G, Chaganti RSK: Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors. Proc Natl Acad Sci USA 89: 11006-11010, 1992.
5. Murty VVVS, George JB, Houldsworth J, Meyers M, Mukherjee AB, Reuter V, Changanti RSK: Allelic loss of somatic differentiation in human germ cell tumors. Oncogene 9: 2245-2251, 1994.
6. Lothe RA, Peltomaki P, Tommerup N, Fossa SD, Stenwig AE, Borresen AL, Nesland JM: Molecular genetic changes in human male germ cell tumors. Lab Invest 73: 606-614, 1995.
7. Al-Jchani RM, Povey S, Delhanty JD, Parrington JM: Loss of heterozygosity on chromosome arms 5q, 11p, 11q, 13q, and 16p in human testicular germ cell tumors. Gene Chromosome Cancer 13: 249-256, 1995.
8. Lothe RA, Hastie N, Heimdal K, Fossa SD, Stenwig AE, Borresen AL: Frequent loss of 11p13 and 11p15 loci in male germ cell tumor. Gene Chromosome Cancer 7: 96-101, 1993.
9. Murty VVVS, Li RG, Houldsworth J, Bronson DL, Reuter VE, Bosl GJ, Chaganti RSK: Frequent allelic deletion and loss of expression characterize the DCC gene in male germ cell tumors. Oncogene 9: 3227-3231, 1994.
10. Peng HQ, Bailey D, Bronson D, Goss PE, Hogg D: Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res 55: 2871-2875, 1995.
11. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Taytigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Söderkwist P, Terry L, Jhanwar S, Berchuck A, Ingelhart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R: BRCA1 mutations in primary breast and ovarian cancer. Science 266: 120-122, 1994.
12. Comelis RS, Vasen HFA, Meijers-Heijboer H, Ford D, vanVliet M, van Tilborg AAG, Cleton FJ, Klijn JGM, Menko FH, Meera Khan P, Cornelisse CJ, Devilee P: Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer. Human Gen 95: 539-544, 1995.
13. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE and the Breast Cancer Linkage Consortium: Risk of cancer in BRCA1 mutation carriers. Lancet 343: 692-695, 1994.
14. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT, Honn KV: Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 55: 1002-1005, 1995.
15. Mori T, Aoki T, Matsubara T, Iida F, XiQun D, Nishihira T, Mori S, Nakamura Y: Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. Cancer Res 54: 1638-1640, 1995.
16. Miki Y, Swenson J, Shattuck-Eidens D, Futreal A, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McCLure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannpn-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994.
17. Papp J, Csokay B, Bosze P, Zalay Z, Toth J, Ponder B, Olah E: Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas. BrJ , Cancer (In press).
18. Knudson AG: Hereditary cancers: clue to mechanisms of carcinogenesis. Br J Cancer 59: 661-666, 1989.
19. Chen Y, Chen C-F, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK, Lee W-H: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791, 1995.
20. Jensen RA, Thompson ME, Jetton TL, Szabo CI, van der Meer R, Helou B, Tronick SR, Page DL, King M-C, Holt JT: BRCA1 is secreted and exhibits properties of a granin. Nat Gen 12: 303-308, 1996.
21. Jabobs IJ, Smith SA, Wiseman RW, Futreal PA, Harrington T, Osborne RJ, Leech V, Molyneux A, Berchuck A, Ponder BAJ, Bast Jr RC: Deletion unit on 17q in epithelian ovarian tumors distal to the familial breast/ovarian cancer locus. Cancer Res 53: 1218-1221, 1993.
22. Damm K: c-ErbA: protooncogene or growth suppressor gene? In: Advances in Cancer Research. Woude GFV, Klein G (eds). Academic Press, New York, pp20-43, 1992.
23. Futreal PA, Soderkvist P, Marks JR: Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsattelite length polymorphisms. Cancer Res 52: 2624-2627, 1992.
24. Rommens JM, Durocher F, McArthur J, Tonin P, LeBlanc JF, Allen T, Samson C, Ferri L, Narod S, Morgan K, et al: Generation of a transcript map at the HSD17B locus centromeric to BRCA1 at 17q21. Genomics 28: 530-542, 1995.
25. Huddart RA, Wooster R, Horwich A, Cooper CS: Microsattelite instability in human testicular germ cell tumours. Br J Cancer 72: 642-645, 1995.
26. Peng HQ, Hogg D, Malkin D, Bailey D, Gallie BL, Bulbul M, Jewett M, Buchanan J, Goss PE: Mutations of the p53 gene do not occur in testis cancer. Cancer Res 53: 3574-3578, 1993.
27. Heimdal K, Lothe RA, Lystad S, Holm R, Fossa SD, Boressen AL: No germline TP53 mutations detected in familiar and bilateral testicular cancer. Gene Chromosome Cancer 6: 92-97, 1993.